Clinical trials: Seborrheic Keratosis (SK)
- Condition Seborrheic Keratosis (SK)
- Funder type Industry (pharma, biotech, devices)
- Has posted results yes
Seborrheic Keratosis (SK)
Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis
Evaluate the safety, tolerability of A-101 when applied to seborrheic keratosis lesions on the back of subjects.
- Trial name
- NCT01986920
- Testing
- A-101 25%, A-101 32.5%, A-101 40%
- Where
- United States
- Volunteers
- 35 people
- Sponsor
- Aclaris Therapeutics, Inc.